T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Clinical trial NCT02457650 · UNKNOWN

Trial details

NCT number: NCT02457650
Sponsor: Shenzhen Second People's Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Bladder Carcinoma Breast Cancer Esophagus Carcinoma Lung Cancer Melanoma Multiple Myeloma Neuroblastoma Ovarian Cancer Synovial Sarcoma Other Metastatic Solid Cancers

Start date: 2015-04-01
Primary completion: 2019-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.